Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18378520 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
Condition: Heart Failure
Interventions: Drug: inactivated trivalent influenza vaccine;   Other: Sterile saline
2 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril

Indicates status has not been verified in more than two years